Total Payments
$6,047
2024 Payments
$1,017
Companies
53
Transactions
309
Medicare Patients
878
Medicare Billing
$109,450
Payment Breakdown by Category
Food & Beverage$5,939 (98.2%)
Education$108.18 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,939 | 307 | 98.2% |
| Education | $108.18 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $479.58 | 17 | $0 (2024) |
| ABBVIE INC. | $417.42 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $391.60 | 27 | $0 (2022) |
| GENZYME CORPORATION | $390.58 | 20 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $297.79 | 19 | $0 (2024) |
| Lundbeck LLC | $281.75 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $272.54 | 16 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $255.49 | 7 | $0 (2024) |
| Celgene Corporation | $220.82 | 10 | $0 (2023) |
| PFIZER INC. | $218.60 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,017 | 40 | PFIZER INC. ($174.20) |
| 2023 | $817.31 | 38 | ABBVIE INC. ($128.71) |
| 2022 | $1,051 | 51 | GENZYME CORPORATION ($164.11) |
| 2021 | $928.61 | 55 | Novartis Pharmaceuticals Corporation ($126.53) |
| 2020 | $852.02 | 46 | UCB, Inc. ($163.35) |
| 2019 | $592.45 | 31 | UCB, Inc. ($76.38) |
| 2018 | $435.55 | 26 | UCB, Inc. ($61.62) |
| 2017 | $352.78 | 22 | Allergan Inc. ($63.30) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $19.89 | General |
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Central Nervous System | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Immune | ||||||
| 10/08/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Neurology | ||||||
| 08/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Neurology | ||||||
| 08/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: NEUROLOGY | ||||||
| 08/05/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Neurology | ||||||
| 07/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN | ||||||
| 06/26/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: EPILEPSY | ||||||
| 06/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: PAIN | ||||||
| 05/15/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Immunology and Neurology | ||||||
| 05/13/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: NEUROLOGY | ||||||
| 05/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PAIN | ||||||
| 04/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.88 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 04/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $138.86 | General |
| Category: Neuropsychiatry | ||||||
| 04/12/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 153 | 232 | $78,354 | $22,162 |
| 2022 | 5 | 173 | 234 | $73,303 | $20,149 |
| 2021 | 6 | 269 | 365 | $124,437 | $35,204 |
| 2020 | 7 | 283 | 378 | $124,065 | $31,935 |
Total Patients
878
Total Services
1,209
Medicare Billing
$109,450
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 129 | $42,441 | $11,783 | 27.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $14,374 | $3,665 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 37 | $7,619 | $2,315 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 16 | $7,088 | $2,235 | 31.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 23 | $6,832 | $2,165 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 100 | $32,900 | $9,714 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 60 | $13,440 | $3,612 | 26.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $14,306 | $3,601 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 37 | $8,177 | $2,089 | 25.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 14 | $4,480 | $1,132 | 25.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 128 | $42,112 | $12,831 | 30.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 58 | 59 | $36,698 | $9,477 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 91 | $20,384 | $6,260 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 29 | $9,280 | $2,403 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 41 | $9,061 | $2,363 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $6,902 | $1,870 | 27.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 126 | $41,454 | $10,377 | 25.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 42 | 42 | $26,124 | $6,925 | 26.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 87 | $19,488 | $4,271 | 21.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 27 | 27 | $10,962 | $3,202 | 29.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 35 | $11,200 | $2,968 | 26.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 32 | $8,428 | $2,484 | 29.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 29 | $6,409 | $1,708 | 26.6% |
About Dr. Elina Pales, DO
Dr. Elina Pales, DO is a Neurology healthcare provider based in Centennial, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386746949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elina Pales, DO has received a total of $6,047 in payments from pharmaceutical and medical device companies, with $1,017 received in 2024. These payments were reported across 309 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($5,939).
As a Medicare-enrolled provider, Pales has provided services to 878 Medicare beneficiaries, totaling 1,209 services with total Medicare billing of $109,450. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Centennial, CO
- Active Since 09/03/2006
- Last Updated 05/02/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386746949
Products in Payments
- AUBAGIO (Drug) $349.42
- NURTEC ODT (Drug) $320.97
- Vimpat (Drug) $316.11
- RYTARY (Drug) $301.61
- UBRELVY (Drug) $286.24
- ZEPOSIA (Drug) $283.49
- XARELTO (Drug) $272.54
- INGREZZA (Drug) $255.49
- VYEPTI (Biological) $239.90
- EMGALITY (Drug) $165.27
- VYVGART HYTRULO (Drug) $164.31
- KESIMPTA (Drug) $156.67
- Aimovig (Biological) $140.64
- MAYZENT (Drug) $116.47
- QULIPTA (Drug) $112.81
- AUSTEDO (Drug) $111.81
- Briviact (Drug) $110.86
- ULTOMIRIS (Biological) $105.33
- Fycompa (Drug) $91.51
- NAMZARIC (Drug) $87.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Centennial
Ronald Murray, M.d, M.D
Neurology — Payments: $509,736
Neurology $509,736
Dr. Kristen Graesser, Md, MD
Neurology — Payments: $38,272
Neurology $38,272
Mr. Steven Gulevich, M.d, M.D
Neurology — Payments: $19,364
Neurology $19,364
Eric Kelts, Md, MD
Neurology — Payments: $3,662
Neurology $3,662
Jane Burnham, Md Phd, MD PHD
Neurology — Payments: $440.90
Neurology $440.90
John Myers, M.d, M.D
Neurology — Payments: $156.09
Neurology $156.09